ASSESSMENT OF TREATMENT OUTCOMES OF Α1-ADRENERGIC BLOCKER THERAPY IN PATIENTS WITH URETERAL CALCULI

Authors

  • Usmonov B. A.

    State Institution "Republican Specialized Scientific and Practical Medical Center of Urology", Uzbekistan, Tashkent ,Tashkent state medical university, Uzbekistan, Tashkent

    Author

  • Abdusatarov A. U.

    State Institution "Republican Specialized Scientific and Practical Medical Center of Urology", Uzbekistan, Tashkent ,Tashkent state medical university, Uzbekistan, Tashkent

    Author

  • Rahmonberdiyev Kh. K.

    State Institution "Republican Specialized Scientific and Practical Medical Center of Urology", Uzbekistan, Tashkent ,Tashkent state medical university, Uzbekistan, Tashkent

    Author

Keywords:
α1-blockers, ureteral stones, drug treatment.
Abstract

This prospective comparative single-center study evaluated the efficacy of α1-adrenergic blockers as a component of combination therapy in patients with ureteral calculi. A total of 118 patients with a solitary ureteral stone located in various ureteral segments were enrolled. After achieving adequate pain control, all participants received conservative treatment aimed at promoting spontaneous stone expulsion for up to 30 days, with weekly ultrasonographic follow-up.
Patients in the control group received drotaverine (40 mg three times daily) together with analgesics, whereas patients in the intervention group additionally received tamsulosin 0.4 mg once daily. The rate of spontaneous passage of distal ureteral stones was significantly higher among patients treated with α1-blockers (p = 0.02). Furthermore, these patients experienced superior pain relief during the follow-up period, even in cases where stone expulsion was not achieved.

References

1. Kaid-Omar Z., Belouatek A., Driouch A. et al. Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients. Prog. Urol. 2001;11:450–454.

2. Worster A., Richards C. Fluids and diuretics for acute ureteric colic. Cochrane Database. Sys. Rev. 2005; СD 004926.

3. Weiss R. M. Physiology and Pharmacology of the renal pelvis and ureter. In Cambell’s Urology (P. C. Walsh, A. B. Retik, T. A. Stamey, E. D., E. D. Vaughan eds). 7 th edn, Vol. 1, Chapt. 25. Philadelphia: WB Saunders Co., 1999;839–869.

4. Lang R. J., Hashitani H., Tonta M. A. et al. Spontaneous electrical and Ca2+ signals in typical and atypical smooth muscle cells and interstitial cell of Cajal-like cells of mouse renal pelvis. J. Physiol. 2007;583:1049–1068.

5. Lang R. J., Tonta M. A., Beata Z. Zolotkowski et al. Pyeloureteric peristalsis: role of atypical smooth muscle cells and interstitial cells of Cajal-like cells as pacemakers. J. Physiol. 2006;576:695–705.

6. Lang R. J., Tonta M. A., Beata Z. Zolotkowski et al. Pyeloureteric peristalsis: role of atypical smooth muscle cells and interstitial cells of Cajal-like cells as pacemakers. J. Physiol. 2006;576:695–705.

7. Rose J. G., Gillenwater J. Y. The effect of adrenergic and cholinergic agents and their blockers upon ureteral activity. Invest. Urol.n1974;11:439–441.

8. Ross J. A., Edmond P., Griffiths J. M. The action of drugs on the intact human ureter. Br. J. Urol. 1967;39:26–29.

9. Sigala S., Dellabella M., Milanese G. Evidence for the presence of alpha1-adrenoceptor subtypes in the human ureter. Neurourol. Urodyn. 2005;24:142–148.

10. Hyoung K. P., Eun Y. C., Byong C. J. et al. Localizations and expressions of α1A, α1-1B and α1-1D adrenoceptors in human ureter. Urol. Res. 2007;35:325–329.

11. O’Leary M. P. Tamsulosin (current clinical experience). Urology. 2001;58(Suppl. 6):42–48. 12. Hartrick C. T., Kovan J. P., Shapiro S. The numeric rating scale for clinical pain measurement: a ratio measure? Pain. Pract. 2003;3(4):310–316. 13. Griffiths D. J. The mechanics of urine transport in the upper urinary tract. 2. The discharge of the bolus into the bladder and dynamics at high rates of flow. Neurourol. Urodyn. 1983;2:167–177.

14. Crowley A. R., Byrne J. C., Vaughan Jr. E. D. et al. The effect of acute obstruction on ureteral function. J. Urol. 1990;143:596–599.

15. Gasser H. S., Grundfest H. Axon diameters in relation to the spike dimensions and the conduction velocity in mammalian A-fibers. Amer. J. Physiol. 1939;127:393–397.

16. Dixon J. S., Gosling J. A. The musculature of the human renal calices, pelvis and upper ureter. J. Anatomy. 1973;135:129–137.

17. McLeod D. G., Reynolds D. G., Swan R. G. Adrenergic mechanisms in the canine ureter. Am. J. Physiol. 1973;224:1054–1059.

18. Davenport K., Timoney A. G., Keeley F. X. A comparative in vitro study to determine the beneficial effect of calcium-channel and a1-adrenoceptor antagonism on human ureteric activity. B.J.U. Int. 2006;98(3):651–655.

Downloads
Published
2026-06-09
Issue
Vol. 2 No. 6 (2026)
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

ASSESSMENT OF TREATMENT OUTCOMES OF Α1-ADRENERGIC BLOCKER THERAPY IN PATIENTS WITH URETERAL CALCULI. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(6), 183-193. https://eurekaoa.com/index.php/5/article/view/1277

Most read articles by the same author(s)